OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
A metabolite panel that differentiates Alzheimer's disease from other dementia types
Longfei Jia, Jianwei Yang, Min Zhu, et al.
Alzheimer s & Dementia (2021) Vol. 18, Iss. 7, pp. 1345-1356
Open Access | Times Cited: 33
Longfei Jia, Jianwei Yang, Min Zhu, et al.
Alzheimer s & Dementia (2021) Vol. 18, Iss. 7, pp. 1345-1356
Open Access | Times Cited: 33
Showing 1-25 of 33 citing articles:
Peripheral and central immune system crosstalk in Alzheimer disease — a research prospectus
Brianne M. Bettcher, Malú G. Tansey, Guillaume Dorothée, et al.
Nature Reviews Neurology (2021) Vol. 17, Iss. 11, pp. 689-701
Open Access | Times Cited: 282
Brianne M. Bettcher, Malú G. Tansey, Guillaume Dorothée, et al.
Nature Reviews Neurology (2021) Vol. 17, Iss. 11, pp. 689-701
Open Access | Times Cited: 282
Open access repository-scale propagated nearest neighbor suspect spectral library for untargeted metabolomics
Wout Bittremieux, Nicole E. Avalon, Sydney P. Thomas, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 42
Wout Bittremieux, Nicole E. Avalon, Sydney P. Thomas, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 42
Lipid metabolism and oxidative stress in patients with Alzheimer's disease and amnestic mild cognitive impairment
Yuting Nie, Changbiao Chu, Qi Qin, et al.
Brain Pathology (2023) Vol. 34, Iss. 1
Open Access | Times Cited: 21
Yuting Nie, Changbiao Chu, Qi Qin, et al.
Brain Pathology (2023) Vol. 34, Iss. 1
Open Access | Times Cited: 21
A detection model for cognitive dysfunction based on volatile organic compounds from a large Chinese community cohort
Bin Jiao, Sizhe Zhang, Yuzhang Bei, et al.
Alzheimer s & Dementia (2023) Vol. 19, Iss. 11, pp. 4852-4862
Open Access | Times Cited: 16
Bin Jiao, Sizhe Zhang, Yuzhang Bei, et al.
Alzheimer s & Dementia (2023) Vol. 19, Iss. 11, pp. 4852-4862
Open Access | Times Cited: 16
Multi-Omic Blood Biomarkers as Dynamic Risk Predictors in Late-Onset Alzheimer’s Disease
Oneil G. Bhalala, Rosie Watson, Nawaf Yassi
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 1231-1231
Open Access | Times Cited: 6
Oneil G. Bhalala, Rosie Watson, Nawaf Yassi
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 1231-1231
Open Access | Times Cited: 6
Open Access Repository-Scale Propagated Nearest Neighbor Suspect Spectral Library for Untargeted Metabolomics
Wout Bittremieux, Nicole E. Avalon, Sydney P. Thomas, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 26
Wout Bittremieux, Nicole E. Avalon, Sydney P. Thomas, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 26
Investigating the causal association between branched-chain amino acids and Alzheimer's disease: A bidirectional Mendelian randomized study
Xiaohang Qian, Xiaoli Liu, Bin Zhang, et al.
Frontiers in Nutrition (2023) Vol. 10
Open Access | Times Cited: 13
Xiaohang Qian, Xiaoli Liu, Bin Zhang, et al.
Frontiers in Nutrition (2023) Vol. 10
Open Access | Times Cited: 13
Application of biomarker-derived fluorescent probes for the detection of Alzheimer's disease
Haitao Ding, Zhiqian Li, Kui Luo, et al.
TrAC Trends in Analytical Chemistry (2023) Vol. 169, pp. 117369-117369
Closed Access | Times Cited: 12
Haitao Ding, Zhiqian Li, Kui Luo, et al.
TrAC Trends in Analytical Chemistry (2023) Vol. 169, pp. 117369-117369
Closed Access | Times Cited: 12
Advances in novel biosensors in biomedical applications
Axin Liang, Weidong Zhao, Tianjian Lv, et al.
Talanta (2024) Vol. 280, pp. 126709-126709
Closed Access | Times Cited: 4
Axin Liang, Weidong Zhao, Tianjian Lv, et al.
Talanta (2024) Vol. 280, pp. 126709-126709
Closed Access | Times Cited: 4
Comprehensive untargeted polar metabolite analysis using solvent switching liquid chromatography tandem mass spectrometry
Jake P. Violi, Connor R. Phillips, David S. Gertner, et al.
Talanta (2025) Vol. 287, pp. 127610-127610
Open Access
Jake P. Violi, Connor R. Phillips, David S. Gertner, et al.
Talanta (2025) Vol. 287, pp. 127610-127610
Open Access
Plasma Metabolic Characteristics and Potential Biomarker Combinations in Schizophrenia Patients With Tardive Dyskinesia
Chenghao Lu, Yeqing Dong, Dan Qi, et al.
Schizophrenia Bulletin (2025)
Closed Access
Chenghao Lu, Yeqing Dong, Dan Qi, et al.
Schizophrenia Bulletin (2025)
Closed Access
Accurate Diagnosis of Alzheimer’s Disease Using Specific Breath Volatile Organic Compounds
Sizhe Zhang, Haokun Liu, Ziyu Ouyang, et al.
ACS Sensors (2025)
Closed Access
Sizhe Zhang, Haokun Liu, Ziyu Ouyang, et al.
ACS Sensors (2025)
Closed Access
Unbiased metabolome screen links serum urate to risk of Alzheimer's disease
Beyazıt Abdurrahman Şanlı, Katherine J. Whittaker, Gamuchirai K. Motsi, et al.
Neurobiology of Aging (2022) Vol. 120, pp. 167-176
Open Access | Times Cited: 14
Beyazıt Abdurrahman Şanlı, Katherine J. Whittaker, Gamuchirai K. Motsi, et al.
Neurobiology of Aging (2022) Vol. 120, pp. 167-176
Open Access | Times Cited: 14
The inhibition of ORMDL3 prevents Alzheimer's disease through ferroptosis by PERK/ATF4/HSPA5 pathway
Yankun Shao, Yilin Xu, Di Huang, et al.
IET Nanobiotechnology (2023) Vol. 17, Iss. 3, pp. 182-196
Open Access | Times Cited: 8
Yankun Shao, Yilin Xu, Di Huang, et al.
IET Nanobiotechnology (2023) Vol. 17, Iss. 3, pp. 182-196
Open Access | Times Cited: 8
Accelerated Breakdown of Phosphatidylcholine and Phosphatidylethanolamine Is a Predominant Brain Metabolic Defect in Alzheimer’s Disease
Jan Krzysztof Blusztajn, Barbara E. Slack
Journal of Alzheimer s Disease (2023) Vol. 93, Iss. 4, pp. 1285-1289
Open Access | Times Cited: 7
Jan Krzysztof Blusztajn, Barbara E. Slack
Journal of Alzheimer s Disease (2023) Vol. 93, Iss. 4, pp. 1285-1289
Open Access | Times Cited: 7
Microbiome and Metabolome Insights into the Role of the Gastrointestinal–Brain Axis in Parkinson’s and Alzheimer’s Disease: Unveiling Potential Therapeutic Targets
Helena U. Zacharias, Christoph Kaleta, François Cossais, et al.
Metabolites (2022) Vol. 12, Iss. 12, pp. 1222-1222
Open Access | Times Cited: 12
Helena U. Zacharias, Christoph Kaleta, François Cossais, et al.
Metabolites (2022) Vol. 12, Iss. 12, pp. 1222-1222
Open Access | Times Cited: 12
Brain regions show different metabolic and protein arginine methylation phenotypes in frontotemporal dementias and Alzheimer’s disease
Fangrong Zhang, Anastasia Rakhimbekova, Tammaryn Lashley, et al.
Progress in Neurobiology (2022) Vol. 221, pp. 102400-102400
Open Access | Times Cited: 12
Fangrong Zhang, Anastasia Rakhimbekova, Tammaryn Lashley, et al.
Progress in Neurobiology (2022) Vol. 221, pp. 102400-102400
Open Access | Times Cited: 12
Characteristics of Drawing Process Differentiate Alzheimer’s Disease and Dementia with Lewy Bodies
Yasunori Yamada, Masatomo Kobayashi, Kaoru Shinkawa, et al.
Journal of Alzheimer s Disease (2022) Vol. 90, Iss. 2, pp. 693-704
Open Access | Times Cited: 8
Yasunori Yamada, Masatomo Kobayashi, Kaoru Shinkawa, et al.
Journal of Alzheimer s Disease (2022) Vol. 90, Iss. 2, pp. 693-704
Open Access | Times Cited: 8
The complete change in bile acids and steroids in systematic metabolomics applied to the intrahepatic cholestasis of pregnancy
Hua-Lin Xu, Yupin Xu, Zhao Guoqiang, et al.
Molecular Omics (2023) Vol. 19, Iss. 5, pp. 418-428
Open Access | Times Cited: 4
Hua-Lin Xu, Yupin Xu, Zhao Guoqiang, et al.
Molecular Omics (2023) Vol. 19, Iss. 5, pp. 418-428
Open Access | Times Cited: 4
Investigating metabolic dysregulation in serum of triple transgenic Alzheimer’s disease male mice: implications for pathogenesis and potential biomarkers
Hongbin Zhuang, Xueshan Cao, Xiaoxiao Tang, et al.
Amino Acids (2024) Vol. 56, Iss. 1
Open Access | Times Cited: 1
Hongbin Zhuang, Xueshan Cao, Xiaoxiao Tang, et al.
Amino Acids (2024) Vol. 56, Iss. 1
Open Access | Times Cited: 1
Decreased plasma nicotinamide and altered NAD+ metabolism in glial cells surrounding Aβ plaques in a mouse model of Alzheimer's disease
Michiko Sekiya, Yasufumi Sakakibara, Yu Hirota, et al.
Neurobiology of Disease (2024), pp. 106694-106694
Open Access | Times Cited: 1
Michiko Sekiya, Yasufumi Sakakibara, Yu Hirota, et al.
Neurobiology of Disease (2024), pp. 106694-106694
Open Access | Times Cited: 1
Biofluid biomarkers for Alzheimer’s disease: past, present, and future
Chunju An, Huimin Cai, Ziye Ren, et al.
Medical Review (2024) Vol. 4, Iss. 6, pp. 467-491
Open Access | Times Cited: 1
Chunju An, Huimin Cai, Ziye Ren, et al.
Medical Review (2024) Vol. 4, Iss. 6, pp. 467-491
Open Access | Times Cited: 1
Associations of the Lipidome with Ageing, Cognitive Decline and Exercise Behaviours
Maria Kadyrov, Luke Whiley, Belinda M. Brown, et al.
Metabolites (2022) Vol. 12, Iss. 9, pp. 822-822
Open Access | Times Cited: 5
Maria Kadyrov, Luke Whiley, Belinda M. Brown, et al.
Metabolites (2022) Vol. 12, Iss. 9, pp. 822-822
Open Access | Times Cited: 5
Discovering Hair Biomarkers of Alzheimer’s Disease Using High Resolution Mass Spectrometry-Based Untargeted Metabolomics
Yu-Hsiang Su, Chih‐Wei Chang, Jen-Yi Hsu, et al.
Molecules (2023) Vol. 28, Iss. 5, pp. 2166-2166
Open Access | Times Cited: 2
Yu-Hsiang Su, Chih‐Wei Chang, Jen-Yi Hsu, et al.
Molecules (2023) Vol. 28, Iss. 5, pp. 2166-2166
Open Access | Times Cited: 2
